NEK2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 9.396200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
2.022600E-01
Normal-vs-Stage2
7.916400E-02
Normal-vs-Stage3
2.460200E-01
Normal-vs-Stage4
1.701980E-01
Stage1-vs-Stage2
2.674800E-01
Stage1-vs-Stage3
8.499600E-01
Stage1-vs-Stage4
5.798800E-01
Stage2-vs-Stage3
4.657600E-01
Stage2-vs-Stage4
7.117000E-01
Stage3-vs-Stage4
7.669200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
1.037010E-01
Normal-vs-AfricanAmerican
1.524620E-01
Normal-vs-Asian
4.633600E-02
Caucasian-vs-AfricanAmerican
8.614200E-01
Caucasian-vs-Asian
6.621800E-01
AfricanAmerican-vs-Asian
6.329200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
9.569600E-02
Normal-vs-Female
9.888200E-02
Male-vs-Female
5.820400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
6.076800E-01
Normal-vs-Age(41-60Yrs)
1.106040E-01
Normal-vs-Age(61-80Yrs)
8.704100E-02
Normal-vs-Age(81-100Yrs)
6.987800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.518600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.546000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.283600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.332000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.951800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.694000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
1.420630E-01
Normal-vs-Daily Drinker
1.119840E-01
Normal-vs-Weekly Drinker
5.444500E-02
Normal-vs-Occasional Drinker
1.243990E-01
Normal-vs-Social Drinker
1.619590E-01
Non Drinker-vs-Daily Drinker
5.326200E-01
Non Drinker-vs-Weekly Drinker
7.324600E-01
Non Drinker-vs-Occasional Drinker
5.200000E-01
Non Drinker-vs-Social Drinker
7.669800E-01
Daily Drinker-vs-Weekly Drinker
8.069600E-01
Daily Drinker-vs-Occasional Drinker
2.312800E-01
Daily Drinker-vs-Social Drinker
8.054600E-01
Weekly Drinker-vs-Occasional Drinker
3.440200E-01
Weekly Drinker-vs-Social Drinker
9.767800E-01
Occasional Drinker-vs-Social Drinker
4.217600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
6.028400E-01
Normal-vs-Grade 2
6.397800E-01
Normal-vs-Grade 3
4.566200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.636100E-04
Grade 1-vs-Grade 3
4.11559999999866E-05
Grade 1-vs-Grade 4
6.028400E-01
Grade 2-vs-Grade 3
1.890240E-01
Grade 2-vs-Grade 4
6.397800E-01
Grade 3-vs-Grade 4
4.566200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
1.984840E-01
Normal-vs-NonDiabetic
7.656200E-02
Diabetic-vs-NonDiabetic
5.037700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
1.674260E-02
Normal-vs-NoPancreatitis
1.177580E-01
Pancreatitis-vs-NoPancreatitis
4.373200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
5.803500E-02
Normal-vs-N1
1.007000E-01
N0-vs-N1
5.674800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
1.61656999999593E-05
Normal-vs-TP53-NonMutant
1.358350E-01
TP53-Mutant-vs-TP53-NonMutant
4.14620004995925E-09
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap